Sichuan Gangtong Medical Equipment Group Co., Ltd (SHE:301515)
China · Delayed Price · Currency is CNY 25.65
+0.26 (1.02%)
At close: Feb 13, 2026
SHE:301515 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Operating Revenue | 603.85 | 751.83 | 840.43 | 766.2 | 678.2 | 561.34 |
Other Revenue | 2.23 | 2.23 | 2.01 | 2.33 | 3.22 | 1.16 |
| 606.08 | 754.06 | 842.44 | 768.53 | 681.41 | 562.49 | |
Revenue Growth (YoY) | -32.70% | -10.49% | 9.62% | 12.78% | 21.14% | - |
Cost of Revenue | 473.73 | 606.55 | 626.51 | 546.74 | 496.67 | 389.27 |
Gross Profit | 132.35 | 147.51 | 215.93 | 221.79 | 184.75 | 173.22 |
Selling, General & Admin | 74.47 | 70.32 | 77.61 | 76.2 | 69.34 | 67.57 |
Research & Development | 23.56 | 24.25 | 29.87 | 26.47 | 22.35 | 17.24 |
Other Operating Expenses | 6.4 | 5.15 | 5.83 | 4.48 | 3.06 | 2.77 |
Operating Expenses | 163.23 | 147.31 | 149.69 | 139.28 | 108.18 | 98.86 |
Operating Income | -30.87 | 0.19 | 66.24 | 82.51 | 76.57 | 74.36 |
Interest Expense | -6.69 | -6.31 | -4.2 | -4.78 | -4.42 | -3.54 |
Interest & Investment Income | 6.61 | 11.24 | 6.34 | 0.99 | 1.46 | 1.25 |
Currency Exchange Gain (Loss) | -0 | -0 | 0.01 | 0.05 | -0.01 | -0.58 |
Other Non Operating Income (Expenses) | -0.96 | -0.47 | -0.51 | 0.93 | 0.75 | -1.76 |
EBT Excluding Unusual Items | -31.91 | 4.65 | 67.88 | 79.69 | 74.34 | 69.72 |
Gain (Loss) on Sale of Investments | 1.29 | 0.96 | - | - | - | - |
Gain (Loss) on Sale of Assets | 0.1 | 0.08 | 17.82 | -0.02 | - | - |
Asset Writedown | -1.85 | -0.06 | 0.03 | -0.03 | -0.1 | -0.69 |
Legal Settlements | - | - | - | -0.27 | -0.22 | -0.77 |
Other Unusual Items | 9.82 | 9.48 | 9.14 | 3.93 | 7.59 | 7.67 |
Pretax Income | -22.55 | 15.1 | 94.87 | 83.3 | 81.61 | 75.94 |
Income Tax Expense | -5.09 | 0.68 | 11.77 | 9.37 | 9.93 | 10.65 |
Net Income | -15.83 | 14.42 | 83.1 | 73.93 | 71.68 | 65.29 |
Net Income to Common | -15.83 | 14.42 | 83.1 | 73.93 | 71.68 | 65.29 |
Net Income Growth | - | -82.64% | 12.40% | 3.14% | 9.79% | - |
Shares Outstanding (Basic) | 97 | 99 | 85 | 75 | 75 | 75 |
Shares Outstanding (Diluted) | 97 | 99 | 85 | 75 | 75 | 75 |
Shares Change (YoY) | 12.52% | 16.20% | 13.89% | -0.00% | 0.00% | - |
EPS (Basic) | -0.16 | 0.15 | 0.97 | 0.99 | 0.96 | 0.87 |
EPS (Diluted) | -0.16 | 0.15 | 0.97 | 0.99 | 0.96 | 0.87 |
EPS Growth | - | -85.06% | -1.31% | 3.14% | 9.79% | - |
Free Cash Flow | -103.66 | -47.94 | -143.06 | 42.88 | 8.81 | 46.66 |
Free Cash Flow Per Share | -1.07 | -0.48 | -1.68 | 0.57 | 0.12 | 0.62 |
Dividend Per Share | 0.120 | 0.120 | 0.258 | - | - | - |
Dividend Growth | -53.49% | -53.49% | - | - | - | - |
Gross Margin | 21.84% | 19.56% | 25.63% | 28.86% | 27.11% | 30.80% |
Operating Margin | -5.09% | 0.03% | 7.86% | 10.74% | 11.24% | 13.22% |
Profit Margin | -2.61% | 1.91% | 9.86% | 9.62% | 10.52% | 11.61% |
Free Cash Flow Margin | -17.10% | -6.36% | -16.98% | 5.58% | 1.29% | 8.29% |
EBITDA | -24.87 | 6.05 | 71.88 | 88.81 | 83.01 | 80.57 |
EBITDA Margin | -4.10% | 0.80% | 8.53% | 11.56% | 12.18% | 14.32% |
D&A For EBITDA | 6.01 | 5.85 | 5.65 | 6.3 | 6.45 | 6.21 |
EBIT | -30.87 | 0.19 | 66.24 | 82.51 | 76.57 | 74.36 |
EBIT Margin | -5.09% | 0.03% | 7.86% | 10.74% | 11.24% | 13.22% |
Effective Tax Rate | - | 4.50% | 12.41% | 11.25% | 12.17% | 14.02% |
Revenue as Reported | 606.08 | 754.06 | 842.44 | 768.53 | 681.41 | 562.49 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.